A cutting-edge multiscale modelling framework integrating molecular dynamics and AI to predict physicochemical properties of formulations, enabling rapid virtual ingredient screening.
The Multiscale MD-AI framework is an innovative solution designed to predict physicochemical properties of surfactant and polymer-based formulations. By integrating molecular dynamics (MD) simulations at various resolutions—atomistic, coarse-grained, and mesoscopic—with machine learning (AI), this framework offers a powerful tool for rapid virtual ingredient screening. It employs flexible parametrisation strategies, matching specific simulation methods to properties based on required spatiotemporal resolution. This approach not only enhances predictive accuracy but also accelerates the design and optimization of new formulations.
Key features:
The framework leverages AI to explore design spaces and map properties efficiently, thereby supporting the development of new formulations that meet specific performance criteria. The combination of physical and data-driven methods allows for comprehensive screening across molecular to macroscopic scales.
Currently at Technology Readiness Level 3, the framework is in the proof-of-concept phase. Over the next 6-12 months, efforts will focus on developing standardized workflows for parameterizing smoothed dissipative particle dynamics (SDPD) simulations, fine-tuning coarse-grained parametrization, and implementing machine learning approaches for high-throughput screening. This phase will demonstrate the framework's predictive capabilities and prepare it for further development.
Lancaster University is a research‑intensive public university in Lancaster, England, with a comprehensive academic portfolio and a strong applied innovation culture. On campus, industry‑engaged labs, shared prototyping spaces, and co‑located incubator facilities sit alongside dedicated business partnership teams, enabling companies to work shoulder‑to‑shoulder with faculty. Proximity to the North West industrial corridor and links with regional NHS partners streamline pilots and scale‑up. Research is supported by competitive funding from UK Research and Innovation councils and Innovate UK, with additional support from NHS/NIHR programs. A dedicated technology transfer office manages IP, licensing, and spinouts, with clear pathways for sponsored research and collaboration.